BRCA1 and ovarian carcinoma: To assess early tumorigenic events, Press et al., conducted a study of noncancerous fallopian tube (with and without BRCA1 pathogenic variants) and ovarian carcinomas from individuals with BRCA1 pathogenic variants [16].